The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

Announcing The Antibody Society’s 2025 James S. Huston Antibody Science Talent Award winner!

by

👏 We are proud to announce Dr. Xin Zhou, Ph.D., as the recipient of the 𝟮𝟬𝟮𝟱 𝗝𝗮𝗺𝗲𝘀 𝗦. 𝗛𝘂𝘀𝘁𝗼𝗻 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗔𝘄𝗮𝗿𝗱!

Dr. Zhou was selected for her pioneering work in protein engineering and chemical biology, advancing understanding of immune signaling, cancer drug resistance, and therapeutic reprogramming. She will present her research at the upcoming 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 & 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 in San Diego this December, and we look forward to her talk.

Dr. Zhou is an Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and of Cancer Biology at Dana-Farber Cancer Institute.

𝗔𝗯𝗼𝘂𝘁 𝗗𝗿. 𝗭𝗵𝗼𝘂 𝗮𝗻𝗱 𝗵𝗲𝗿 𝗹𝗮𝗯:

She holds a Ph.D. in Bioengineering from Stanford University School of Medicine and completed postdoctoral research at University of California, San Francisco as a Merck – Damon Runyon Cancer Research Foundation Fellow. Since joining Dana-Farber and Harvard in 2022, her lab has developed technologies in protein engineering and chemical biology to study cancer and immune signaling, drug resistance, and metastasis, and to engineer self-regulated antibodies, enzymes, and cells for therapeutic reprogramming.

𝗛𝗲𝗿 𝗺𝗮𝗻𝘆 𝗵𝗼𝗻𝗼𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

V Foundation Women Scientists Innovation Award for Cancer Research, NIH Director’s New Innovator Award (DP2), Damon Runyon Dale F. Frey Award for Breakthrough Scientists, Helen Gurley Brown Foundation Trailblazer Award, Dana-Farber Innovations Therapeutic Accelerator LEAP Award, MIT Technology Review Innovators Under 35 (China region), PEGS Protein & Antibody Engineering Summit Young Scientist Keynote Award, and the NIH K99/R00 Pathway to Independence Award.

𝗠𝗮𝗻𝘆 𝗰𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗗𝗿. 𝗭𝗵𝗼𝘂 𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗹𝗹 𝗱𝗲𝘀𝗲𝗿𝘃𝗲𝗱 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻! 🏆

If you are an early-career scientist interested in participating in next year’s award, you can learn more about the submission guidelines.

Precision in Antibody Format Design – Webinar with Dotmatics & BioGlyph.

by

In next generation antibody discovery, precision is everything. Even small oversights can cascade through workflows, compromising data and decisions.

Join experts from Dotmatics and BioGlyph in a webinar hosted by The Antibody Society to explore how precision from sequence design to data integration can transform antibody R&D.

We’ll highlight how platforms like Luma and BioGlyph tackle challenges in data fidelity, workflow integration, and early error detection, helping scientists make smarter, faster decisions.

𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀:

  • Fernando Garces, Ph.D. – CEO, BioGlyph
  • Christian Olsen, Ph.D. – VP, Strategy, Protein Therapeutics, Dotmatics

𝗗𝗮𝘁𝗲: October 16, 2025 | 𝗧𝗶𝗺𝗲: 12:00 PM EDT / 9:00 AM PDT

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here: https://events.teams.microsoft.com/event/293844e7-fe36-4d3e-9b06-aab3652ebd0f@7384e819-4d00-4994-9c4a-b036004b889f

A𝗱𝗱 𝘁𝗵𝗶𝘀 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝘁𝗼 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿: https://mcusercontent.com/281543b4b89e8ab3d8438030b/files/f33ea104-7356-3ae4-d9ea-8a6ae3a1bb33/Upcoming_Webinar_Dotmatics_amp_TAbS_team_up_to_discuss_Unprecedented_Precision_in_Antibody_Format_Design_Oct16_2025.ics

Join Tabs and the AIRR-C for the First TAbS Townhall!

by

TAbS is excited to welcome you to the very first Townhall Meeting on October 15, 2025! 🎉 Join the event on Zoom using this LINK as they share the latest updates about the organization, highlight new and ongoing programs, and introduce the committees and resources available to members. This will also be a great opportunity for committee members to connect and get to know one another ahead of the upcoming programmatic year.

Can’t make it live? No problem! The session will be recorded! Don’t forget to share this invitation with fellow antibody enthusiasts who may want to join in.

The Antibody Society (TAbS) Call for Abstracts at AET San Diego 2025 | Dec 14-17

by

Are you a 𝘀𝘁𝘂𝗱𝗲𝗻𝘁, 𝗽𝗼𝘀𝘁𝗱𝗼𝗰, or 𝗲𝗮𝗿𝗹𝘆 𝗰𝗮𝗿𝗲𝗲𝗿 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 working in academia, biotech, or pharma? If your research is antibody-focused, this is your chance to share it with a global community of scientists and industry leaders.

We’re excited to invite abstract submissions for this year’s 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 & 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 (𝗔𝗘𝗧) 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 in San Diego, taking place December 14-17, 2025.

Selection Criteria

  • All abstracts will be reviewed by our judges and 10 participants will be selected.

  • Selected participants will have the chance to present their poster at AET San Diego 2025.

  • Each selected participant will receive 1 complimentary full-conference pass.

Details to include in your submission

  • Conference title: AET San Diego

  • Title of your research topic

  • Name(s) of author(s)

  • Relevant industry/academic affiliations

  • Abstract (maximum half a page)

𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝘁𝗼 𝘀𝘂𝗯𝗺𝗶𝘁: October 17, 2025

𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗵𝗲𝗿𝗲: https://docs.google.com/forms/d/e/1FAIpQLSfael-7rtpiNTxT8t2QX63WhVhJSeQ-NkyOvfC70nc1xEWw2g/viewform

𝗣𝗹𝗲𝗮𝘀𝗲 𝗻𝗼𝘁𝗲: Travel and accommodation are not included, and this opportunity is open only to those who are not already registered attendees.

𝗧𝗔𝗯𝗦 𝗺𝗲𝗺𝗯𝗲𝗿𝘀, you are very welcome to share this within your networks so we can reach as many promising researchers as possible.

We look forward to receiving your abstracts!

The Antibody Society | Informa Connect Life Sciences

Episode 19 of the On AIRR podcast is here! What does it take to prepare for the next pandemic?

by

In this episode, we explore ReVAMPP (Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness), an NIH-funded initiative focused on pathogens that pose significant public health risks, including emerging viruses with pandemic potential.

Together with Dr. Lauren Williamson and Dr. Robert Carnahan (Vanderbilt University Medical Center) and Dr. Matthew Vogt (University of North Carolina), we discuss how ReVAMPP enhances the development of effective vaccines and monoclonal antibodies. We dive into prototype pathogen strategies for identifying broadly neutralizing antibodies, the challenge of balancing breadth and potency in therapeutics, and innovative screening methods that could transform our ability to respond to future outbreaks.

Tune in for a behind-the-scenes look at how collaborative science is shaping the future of global health!

Listen now via your favorite podcast platform or here: http://onairr.airr-community.org. New episodes will be released monthly.